Asad Rizvi, MD
Interventional Cardiology · Hartford, CTNPI 1912907346
Payments from drug & device makers
What this record shows
23 manufacturers reported payments, led by Boston Scientific at 39.1% of the total. Reporting peaked in 2020 at $1,607 and has fallen 88.5% since, to $185 in 2025. That places this record below the midpoint for interventional cardiology clinicians in CT, where the typical reported total is $5,446.
Across 101 payments — averaging $46.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Edwards Lifesciences$1K
- Medtronic$691
- Bard Peripheral Vascular, Inc.$146
- Angiodynamics, Inc.$129
- Abbott$94
- plus $575 from 17 others
What the payments were for
- Travel & lodging$2,07145%
- Food & beverage$2,57955%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 10 | $1,816 |
| Edwards Lifesciences | 28 | $1,199 |
| Medtronic(2 entities) | 30 | $691 |
| Bard Peripheral Vascular, Inc. | 1 | $146 |
| Angiodynamics, Inc. | 2 | $129 |
| Abbott | 3 | $94 |
| Penumbra, Inc. | 3 | $84 |
| Shockwave Medical, Inc | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| Cardiva Medical, Inc. | 3 | $52 |
| Johnson & Johnson | 3 | $45 |
| Madrigal Pharmaceuticals | 1 | $33 |
| Merck | 1 | $30 |
| Amgen | 1 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $24 |
| Chiesi USA, Inc. | 1 | $22 |
| Terumo Medical Corporation | 1 | $21 |
| Intercept Pharmaceuticals, Inc. | 1 | $21 |
| Biotronik Inc. | 1 | $20 |
| Opsens Inc. | 1 | $20 |
| AstraZeneca | 1 | $19 |
| Biomerieux Inc | 1 | $15 |
| GE HealthCare | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,650 in reported general payments places this provider in the 40th percentile of 73 interventional cardiology providers in Connecticut.
See all interventional cardiology providers in Connecticut →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Hartford
- Craig ThompsonHartford$222K
- Abdul QaziHartford$38K
- Sarfaraz MemonHartford$30K
- Boskey PatelHartford$20K
- Joseph IngrassiaHartford$16K
- Talhat AzemiHartford$12K
- Bryan PiccirilloHartford$12K
- Immad SadiqHartford$9K
- Daniel FramHartford$3K
- Arslan MasoodHartford$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.